| PALM CITY, Fla., Nov. 4, 2011 (GLOBE NEWSWIRE) -- GelStat Corporation (Other OTC:GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain, inflammation and sleep disorders, is pleased to announce that Mr. Paul W. Bucha has joined its Board of Directors. Mr. Bucha has over 40 years of experience, serving a number of senior executive level leadership positions within a wide range of industries i...continued GSAC gelstat migrane migranes |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Friday, November 4, 2011
GelStat Corporation Appoints Paul W. Bucha to our Board of Directors
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment